Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Smg5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SMG5 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Smg5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SMG5 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Smg5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SMG5 mRNA | CTD | PMID:21570461 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMG5 mRNA | CTD | PMID:28628672 | aflatoxin B1 | increases expression | ISO | Smg5 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of SMG5 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases expression | ISO | Smg5 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in decreased expression of SMG5 mRNA | CTD | PMID:33354967 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of SMG5 gene | CTD | PMID:27153756 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of SMG5 mRNA | CTD | PMID:33212167 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of SMG5 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases expression | ISO | Smg5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SMG5 mRNA | CTD | PMID:19770486 | bisphenol A | affects expression | ISO | Smg5 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of SMG5 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of SMG5 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | EXP | | 6480464 | [[ginger extract results in increased abundance of Oils and Volatile] which co-treated with bisphenol A] affects the expression of SMG5 protein | CTD | PMID:33376534 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SMG5 mRNA | CTD | PMID:29275510 | bisphenol A | increases expression | ISO | Smg5 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SMG5 mRNA | CTD | PMID:30816183 and PMID:34947998 | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMG5 mRNA | CTD | PMID:28628672 | chlordecone | increases expression | ISO | Smg5 (Mus musculus) | 6480464 | Chlordecone results in increased expression of SMG5 mRNA | CTD | PMID:33711761 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of SMG5 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SMG5 mRNA | CTD | PMID:20106945 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMG5 mRNA | CTD | PMID:28628672 | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of SMG5 mRNA | CTD | PMID:28302478 | diquat | decreases expression | ISO | Smg5 (Mus musculus) | 6480464 | Diquat results in decreased expression of SMG5 protein | CTD | PMID:36851058 | elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SMG5 mRNA | CTD | PMID:19244175 | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of SMG5 mRNA | CTD | PMID:19244175 | epoxiconazole | increases expression | ISO | Smg5 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SMG5 mRNA | CTD | PMID:35436446 | ethanol | affects splicing | ISO | Smg5 (Mus musculus) | 6480464 | Ethanol affects the splicing of SMG5 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Smg5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SMG5 mRNA | CTD | PMID:22206623 | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of SMG5 protein | CTD | PMID:37730182 | gentamycin | increases expression | ISO | Smg5 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of SMG5 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMG5 mRNA | CTD | PMID:28628672 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of SMG5 mRNA | CTD | PMID:28988120 | paracetamol | affects expression | ISO | Smg5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SMG5 mRNA | CTD | PMID:17562736 | perfluorohexanesulfonic acid | decreases expression | ISO | Smg5 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of SMG5 mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Smg5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SMG5 mRNA | CTD | PMID:36331819 | pirinixic acid | increases expression | ISO | Smg5 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SMG5 mRNA | CTD | PMID:18301758 | potassium dichromate | decreases expression | ISO | Smg5 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of SMG5 mRNA | CTD | PMID:23608068 | selenium atom | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SMG5 mRNA | CTD | PMID:19244175 | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of SMG5 mRNA | CTD | PMID:19244175 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of SMG5 mRNA | CTD | PMID:31533062 | thioacetamide | increases expression | ISO | Smg5 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of SMG5 mRNA | CTD | PMID:23411599 and PMID:34492290 | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of SMG5 mRNA | CTD | PMID:28542535 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of SMG5 gene | CTD | PMID:29154799 | vitamin E | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SMG5 mRNA | CTD | PMID:19244175 | vitamin E | increases expression | EXP | | 6480464 | Vitamin E results in increased expression of SMG5 mRNA | CTD | PMID:19244175 | |